Research Output
To screen or not to screen? Examining the arguments against screening for atrial fibrillation.
  Atrial fibrillation (AF) is the most common cardiac arrhythmia, with a lifetime risk of 1 in 4 of developing AF over the age of 40 years. Around 40% of patients are asymptomatic, which is of concern as AF is a major risk factor for stroke. Early detection and appropriate management reduces stroke risk by two-thirds. AF screening is now recommended in international guidelines, but there are some common arguments against screening. Overall, to be of value any screening program must fulfil the World Health Organisation (WHO) Wilson and Jungner criteria for screening programs. In this paper we address the common arguments and determine if AF screening fulfils the WHO criteria.

  • Type:

    Review

  • Date:

    24 May 2017

  • Publication Status:

    Published

  • DOI:

    10.1016/j.hlc.2017.05.118

  • Cross Ref:

    S1443950617304821

  • ISSN:

    1443-9506

  • Library of Congress:

    RA Public aspects of medicine

  • Dewey Decimal Classification:

    613 Personal health & safety

  • Funders:

    Edinburgh Napier Funded

Citation

Neubeck, L., Orchard, J., Lowres, N., & Freedman, S. B. (2017). To screen or not to screen? Examining the arguments against screening for atrial fibrillation. Heart, Lung and Circulation, 26(9), 880-886. https://doi.org/10.1016/j.hlc.2017.05.118

Authors

Keywords

Atrial fibrillation, screening technology,

Monthly Views:

Available Documents